Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities.

Published on Mar 13, 2021in European Journal of Medicinal Chemistry6.514
路 DOI :10.1016/J.EJMECH.2021.113360
Mostafa M. Elbadawi3
Estimated H-index: 3
(Hiroshima University),
Wagdy M. Eldehna26
Estimated H-index: 26
(Kafrelsheikh University)
+ 8 AuthorsMohammad M. Al-Sanea12
Estimated H-index: 12
Sources
Abstract
ABSTRACT As a front-runner selective CA IX inhibitor currently in Phase Ib/II clinical trials, SLC-0111 has been herein exploited as a lead molecule for development of new different sets of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides incorporating different functionalities; primary sulfonamide (5a-f), free carboxylic (8a, 8d), ethyl ester (8b, 8e), acetyl (8c, 8f) and nitro (10a, 10b), as potential carbonic anhydrase (CA, EC 4.2.1.1) inhibitors. All the prepared analogues have been examined for their CA inhibitory activities towards four human (h) isoenzymes, hCA I, II, IX and XII. Interestingly, replacement of SLC-0111 ureido linker with the flexible sulfonyl acetamide linker, as well as linker branching and elongation strategies successfully enhanced the inhibitory action toward hCA IX isoform, such as in sulfones 5a-d and 5f which displayed better activity than SLC-0111. Furthermore, sulfonamide-based sulfone (5f) and carboxylic acid-based sulfones (8a and 8d) demonstrated interesting selectivity toward the tumor-related hCA IX isoform over both hCA I and hCA II, which suggests them as promising candidates for further development as potential anticancer candidates. Thereafter, the anti-proliferative action for sulfones 5f, 8a and 8d was examined against breast (MCF-7) and colon (HCT-116) cancer cell lines. Also, sulfone 5f was further assessed for its impact on the cell cycle progression and apoptosis in HCT-116 cells.
馃摉 Papers frequently viewed together
References37
Newest
#1Marina Petrenko (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 3
#2Antje G眉ttler (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 11
Last. Matthias Bache (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 29
view all 8 authors...
Abstract Hypoxia plays a key role in tumor progression and resistance to radiotherapy. Expression of the transmembrane-tethered enzyme carbonic anhydrase IX (CA IX) is strongly induced by hypoxia. High CA IX expression levels correlate with poor prognosis in cancer patients. Previously, we showed that the downregulation of CA IX expression by siRNA interference and the inhibition of CA IX activity results in increased cytotoxicity, inhibition of migration and radiosensitization of hypoxic cancer...
Source
#1Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
#2Sara T. Al-Rashood (KSU: King Saud University)H-Index: 11
Last. Ahmed M. El Kerdawy (Cairo University)H-Index: 14
view all 6 authors...
The serine/threonine protein kinases CDK2 and GSK-3尾 are key oncotargets in breast cancer cell lines, therefore, in the present study three series of oxindole-benzofuran hybrids were designed and s...
Source
#1Ran An (SPU: Shenyang Pharmaceutical University)H-Index: 5
#2Bin Lin (SPU: Shenyang Pharmaceutical University)H-Index: 14
Last. Chun Guo (SPU: Shenyang Pharmaceutical University)H-Index: 9
view all 12 authors...
Abstract A series of artemisinin-sulfonamide hybrids (1-16) have been designed and synthesized by using molecular hybridization approach and investigated for the inhibitory activity of four human (h) carbonic anhydrases (CAs, EC 4.2.1.1), hCA I, II, IX and XII. The results indicated most of the target compounds showed better CA IX and CA XII inhibitory activity than the starting segment sulfanilamide. Among all the compounds, compound 3 (IC50: 5 nM) showed the best CA IX inhibitory efficacy. The...
Source
#1Andrea Angeli (UniFI: University of Florence)H-Index: 25
#2Fabrizio Carta (UniFI: University of Florence)H-Index: 52
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 15 authors...
The tumor microenvironment is crucial for the growth of cancer cells, triggering particular biochemical and physiological changes, which frequently influence the outcome of anticancer therapies. The biochemical rationale behind many of these phenomena resides in the activation of transcription factors such as hypoxia-inducible factor 1 and 2 (HIF-1/2). In turn, the HIF pathway activates a number of genes including those involved in glucose metabolism, angiogenesis, and pH regulation. Several car...
Source
A series of urea/thiourea substituted benzoxaboroles was investigated for the inhibition of the three carbonic anhydrases encoded by Vibrio cholerae (VchCA伪, VchCA尾, and VchCA纬). In particular, ben...
Source
Last. Radwan El-Haggar (Helwan University)H-Index: 7
view all 14 authors...
ABSTRACT Herein we describe design and synthesis of different series of novel small molecules featuring 3-methylthiazolo[3,2-a]benzimidazole moiety (as a tail) connected to the zinc anchoring benzenesulfonamide moiety via ureido (7), enaminone (12), hydrazone (14), or hydrazide (15) linkers. The newly prepared conjugates have been screened for their inhibitory activities toward four human (h) carbonic anhydrase (CA, EC 4.2.1.1) isoforms: hCA I, II, IX and XII. Thereafter, the urea and enaminone ...
Source
#1Ahmed SabtH-Index: 4
#2Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
Last. Hatem A. Abdel-AzizH-Index: 36
view all 7 authors...
Human health in the current medical era is facing numerous challenges, especially cancer. So, the therapeutic arsenal for cancer should be unremittingly enriched with novel small molecules that sel...
Source
#1Alessandro Bonardi (UniFI: University of Florence)H-Index: 12
#2Alessio Nocentini (UniFI: University of Florence)H-Index: 29
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 12 authors...
The 鈥渢ail-approach鈥 has become a milestone in human carbonic anhydrase inhibitor (hCAI) design for various therapeutics, including antiglaucoma agents. Beside the classical hydrophobic/hydrophilic ...
Source
#1Aleksandrs Pustenko (Riga Technical University)H-Index: 4
#2Alessio Nocentini (UniFI: University of Florence)H-Index: 29
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 7 authors...
The clinically used antibiotic Furagin and its derivatives possess inhibitory activity on human (h) carbonic anhydrases (CA, EC 4.2.1.1), some of which are highly expressed in various tissues and malignancies (hCA IX/XII). Furagin exhibited good hCA IX and XII inhibition with KIs of 260 and 57 nM, respectively. It does not inhibit off-target CA I and poorly inhibited CA II (KI = 9.6 muM). Some synthesised Furagin derivatives with aminohydantoin moieties as zinc binding group exhibited weak inhib...
Source
#1Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
#2Alessio Nocentini (UniFI: University of Florence)H-Index: 29
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 9 authors...
Pursuing our effort for developing effective inhibitors of the cancer-related hCA IX isoform, here we describe the synthesis of novel benzofuran-based carboxylic acid derivatives, featuring the ben...
Source
Cited By3
Newest
#1Mostafa M. Elbadawi (Kafrelsheikh University)H-Index: 3
#2Ahmed I. Khodair (Kafrelsheikh University)H-Index: 19
Last. Khaled R.A. Abdellatif (Beni-Suef University)H-Index: 22
view all 6 authors...
Abstract null null In our endeavors to develop potent anticancer agents, novel two series of 3,5-disubstituted-2-thiohydantoins 5a鈥揷 and the S-methyl counterparts 6a鈥揷 were designed and synthesized. The structural modifications were based on some reported thiohydantoins derivatives which showed promising antiproliferative activity. The activity of the compounds was verified via the in vitro cytotoxicity assay against prostate (PC-3) and breast (MCF-7) cancer cell lines along with normal lung fib...
Source
#1Yichao Wan (Hunan University of Science and Technology)H-Index: 5
#2Guoqing Fang (Hunan University of Science and Technology)
Last. Zilong Tang (Hunan University of Science and Technology)H-Index: 7
view all 5 authors...
Abstract null null Currently, the arise of drug resistance and undesirable off-target effects of anti-cancer agents are major challenges for cancer treatment, which energizes medicinal chemists to develop more anti-cancer agents with high efficiency and low toxicity continuously. Sulfonamide derivatives are a class of promising compounds with diverse biological activities including anti-cancer, and parts of them have been marketed for cancer therapy, such as Belinostat, ABT-199 and Amsacrine. In...
Source
#1Assem H. Eldeeb (Egyptian Russian University)
#2Mahmoud F. Abo-Ashour (Egyptian Russian University)H-Index: 10
Last. Claudiu T. Supuran (UniFI: University of Florence)H-Index: 155
view all 10 authors...
Abstract New series of benzenesulfonamide and benzoic acid derivatives were designed and synthesized using tail/dual tail approach to improve potency and selectivity as carbonic anhydrase inhibitors. The synthesized compounds evaluated as CAIs against isoforms hCA I, II, IV and IX with AAZ as standard inhibitor. The benzenesulfonamide derivatives 7a-d, 8a-h, 12a-c, 13a and 15a-c showed moderate to potent inhibitory activity with selectivity toward isoform hCA II, especially, compound 13a with (K...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.